Back
PTC Therapeutics Stock Price Chart
Sponsored
PTCT
Sponsored
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing selling pressure, which indicates risk of future bearish movement.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.81 | Buy |
20-day SMA: | 43.67 | Buy |
50-day SMA: | 40.62 | Buy |
200-day SMA: | 34.19 | Buy |
8-day EMA: | 46.55 | Buy |
20-day EMA: | 44.07 | Buy |
50-day EMA: | 41.1 | Buy |
200-day EMA: | 35.83 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 66.75 | Buy |
Chaikin Money Flow: | -849912 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.04 - 46.16) | Buy |
Bollinger Bands (100): | (32.47 - 41.53) | Buy |
PTC Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 50.29 while PTCT 8-day simple moving average is 45.81, which is a Buy signal.
- The stock price of PTCT is 50.29 while PTC Therapeutics 20-day SMA is 43.67, which makes it a Buy.
- PTC Therapeutics 50-day simple moving average is 40.62 while PTCT share price is 50.29, making it a Buy technically.
- PTCT stock price is 50.29 and PTC Therapeutics 200-day simple moving average is 34.19, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a Buy
The current PTC Therapeutics [PTCT] share price is $50.29. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
PTC Therapeutics Stock Info
Market Cap:
3.88B
Price in USD:
50.29
Share Volume:
1.45M
PTC Therapeutics 52-Week Range
52-Week High:
54.16
52-Week Low:
23.58
Buy
51
PTC Therapeutics (PTCT)
is a Buy
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?
The PTC Therapeutics stock price is 50.29 USD today. -
Will PTCT stock go up or go down?
PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is PTC Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is not overvalued.
Is PTC Therapeutics Stock a Buy?
- PTC Therapeutics share price is 50.29 while PTCT 8-day exponential moving average is 46.55, which is a Buy signal.
- The stock price of PTCT is 50.29 while PTC Therapeutics 20-day EMA is 44.07, which makes it a Buy.
- PTC Therapeutics 50-day exponential moving average is 41.10 while PTCT share price is 50.29, making it a Buy technically.
- PTCT stock price is 50.29 and PTC Therapeutics 200-day simple moving average is 35.83, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.82 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
- PTCT Moving Average Covergence Divergence (MACD) indicator is 2.11, suggesting PTC Therapeutics is a Buy
- PTC Therapeutics Relative Strength Index (RSI) is 66.75, which suggest PTC Therapeutics is overbought
- The Bollinger Bands (25) for PTC Therapeutics is (40.04 - 46.16), which suggest PTC Therapeutics is a Buy
- The Bollinger Bands (100) for PTC Therapeutics is (32.47 - 41.53), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.